Controversies Around Measuring Drug Toxicity: FDA and GI Perspectives

Gastroenterology - United Kingdom
doi 10.1053/j.gastro.2019.10.014
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Measuring the Impact of the Food and Drug Administration (Fda) Unapproved Drug Initiative (Udi) on Drug Prices and Expenditures

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Myocardial Revascularisation - Current Perspectives and Controversies

Journal of Cardiology & Cardiovascular Therapy
2018English

OxyContin, the FDA, and Drug Control

AMA journal of ethics
Health PolicyEthicsHealthIssuesLegal Aspects
2014English

2017 FDA Drug Approvals

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2018English

The Microbiome and Women’s Health: Perspectives and Controversies

BJOG: An International Journal of Obstetrics and Gynaecology
GynecologyObstetrics
2019English

Drug Toxicity.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1990English

From the FDA: Epilepsy Drug Approved

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1994English

Genomics and Drug Toxicity

Science
MultidisciplinaryPhilosophy of ScienceHistory
2004English

Ecological Turn-Around – Trends and Perspectives

Acta Prosperitatis
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy